63 related articles for article (PubMed ID: 35951171)
1. A novel non-invasive colorectal cancer diagnostic method: Volatile organic compounds as biomarkers.
Alustiza M; Ripoll L; Canals A; Murcia O; Martínez-Roca A; García-Heredia A; Giner-Calabuig M; Jover R; Vidal L
Clin Chim Acta; 2023 Mar; 542():117273. PubMed ID: 36863694
[TBL] [Abstract][Full Text] [Related]
2. Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions.
Shen Y; Wang D; Yuan T; Fang H; Zhu C; Qin J; Xu X; Zhang C; Liu J; Zhang Y; Wen Z; Tang J; Wang Z
Clin Epigenetics; 2023 Feb; 15(1):26. PubMed ID: 36803423
[TBL] [Abstract][Full Text] [Related]
3. Expression Levels and Clinical Significance of Serum miR-497, CEA, CA24-2, and HBsAg in Patients with Colorectal Cancer.
Liu Y; Chen J
Biomed Res Int; 2022; 2022():3541403. PubMed ID: 35993056
[TBL] [Abstract][Full Text] [Related]
4. Additive pre-diagnostic and diagnostic value of routine blood-based biomarkers in the detection of colorectal cancer in the UK Biobank cohort.
Tanriver G; Kocagoncu E
Sci Rep; 2023 Jan; 13(1):1367. PubMed ID: 36693981
[TBL] [Abstract][Full Text] [Related]
5. Detection of Chitinase 3-Like 1 in Symptomatic Primary Care Patient Faecal Samples is Not a Reliable Biomarker of Colonic Lesions.
Keenan JI; Aitchison A; Frizelle FA; Hock BD
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2289-2293. PubMed ID: 37505758
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the
Matsunaga K; Sasaki K; Hata K; Nozawa H; Kawai K; Murono K; Emoto S; Yokoyama Y; Sonoda H; Ueda K; Kuriyama S; Yamada T; Yoshida H; Ishihara S
Oncol Lett; 2023 May; 25(5):192. PubMed ID: 37113399
[TBL] [Abstract][Full Text] [Related]
7. Segmental or right hemi-colectomy? The optimal surgical procedure for transverse colon cancer: a propensity score-matched, multicenter, retrospective study.
Kanaka S; Matsuda A; Yamada T; Miyamoto Y; Yokoyama Y; Matsumoto S; Sonoda H; Ohta R; Shinji S; Sekiguchi K; Baba H; Yoshida H
Int J Colorectal Dis; 2023 Mar; 38(1):58. PubMed ID: 36864355
[TBL] [Abstract][Full Text] [Related]
8. Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study).
Matsuoka H; Yamada T; Ohta R; Yoshida Y; Watanabe T; Takahashi M; Kosugi C; Fukazawa A; Kuramochi H; Matsuda A; Sonoda H; Yoshida H; Hasegawa S; Sakamoto K; Otsuka T; Hirata K; Koda K;
Int J Clin Oncol; 2022 Dec; 27(12):1859-1866. PubMed ID: 36201089
[TBL] [Abstract][Full Text] [Related]
9. A prognostic six-gene expression risk-score derived from proteomic profiling of the metastatic colorectal cancer secretome.
Robles J; Pintado-Berninches L; Boukich I; Escudero B; de Los Rios V; Bartolomé RA; Jaén M; Martín-Regalado Á; Fernandez-Aceñero MJ; Imbaud JI; Casal JI
J Pathol Clin Res; 2022 Nov; 8(6):495-508. PubMed ID: 36134447
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Immunocyte-Derived Ratios Predict Postoperative Recovery of Gastrointestinal Motility after Colorectal Cancer Surgery.
Firut A; Margaritescu DN; Turcu-Stiolica A; Bica M; Rotaru I; Patrascu AM; Radu RI; Marinescu D; Patrascu S; Streba CT; Surlin V
J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37834982
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma.
Cadamuro M; Sarcognato S; Camerotto R; Girardi N; Lasagni A; Zanus G; Cillo U; Gringeri E; Morana G; Strazzabosco M; Campello E; Simioni P; Guido M; Fabris L
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902188
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylcholine as a predictor of postoperative complications after colorectal cancer surgery.
Matsuda A; Yamada M; Matsumoto S; Sakurazawa N; Yamada T; Matsutani T; Miyashita M; Uchida E
Surg Today; 2018 Oct; 48(10):936-943. PubMed ID: 29774420
[TBL] [Abstract][Full Text] [Related]
13. Blood Galectin-3 Levels Predict Postoperative Complications after Colorectal Cancer Surgery.
Matsuda A; Yamada M; Matsumoto S; Sakurazawa N; Kawano Y; Sekiguchi K; Yamada T; Matsutani T; Miyashita M; Yoshida H
J Nippon Med Sch; 2019; 86(3):142-148. PubMed ID: 31292325
[TBL] [Abstract][Full Text] [Related]
14. Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer.
Ng L; Wan TM; Lam CS; Chow AK; Wong SK; Man JH; Li HS; Cheng NS; Pak RC; Cheung AH; Yau TC; Lo OS; Foo DC; Poon JT; Poon RT; Pang RW; Law WL
PLoS One; 2015; 10(5):e0126219. PubMed ID: 25961724
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of proinflammatory biomarker interleukin-6 (IL-6) as a predictor of postoperative complications after elective colorectal surgery.
Procházka V; Lacina L; Smetana K; Svoboda M; Skřivanová K; Beňovská M; Jarkovský J; Křen L; Kala Z
World J Surg Oncol; 2023 Dec; 21(1):384. PubMed ID: 38098074
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin Levels Are Persistently Elevated for 4 weeks Following Minimally Invasive Colorectal Cancer Resection.
Shantha Kumara H; Jaspreet S; Pettke E; Miyagaki H; Herath SA; Yan X; Cekic V; Whelan RL
Surg Innov; 2023 Feb; 30(1):7-12. PubMed ID: 35225101
[TBL] [Abstract][Full Text] [Related]
17. The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery.
Sekiguchi K; Matsuda A; Yamada M; Matsumoto S; Sakurazawa N; Kawano Y; Yamada T; Miyashita M; Yoshida H
Int J Clin Oncol; 2022 Nov; 27(11):1706-1716. PubMed ID: 35951171
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
